Company intelligence / Profile preview
Franco-Indian Pharmaceuticals Pvt. Ltd.
- Ownership
- Private
- Development stage
- Commercial
Overview
Franco‐Indian Pharmaceuticals has a long history of introducing first-in-class products to the Indian market including India’s first oral penicillin and cortisone. Its portfolio covers diabetes care with metformin (“Glyciphage”), hematinics (“Dexorange”), dermatologicals for vitiligo/psoriasis (“Melanocyl”), probiotics (“Lactisyn”), bronchodilators (“A‐Phyl”) and more[3][4][5]. The company’s products are widely available in India and exported internationally.
- Therapeutic areas
- PulmonologyEndocrinologyHematologyDermatologyGastroenterologyWomen's Health
- Modalities
- Small moleculesvitamins/mineralsprobioticscorticosteroids
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Franco-Indian Pharmaceuticals Pvt. Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Franco-Indian Pharmaceuticals Pvt. Ltd..